Eksempler på brug af Plaque psoriasis på Engelsk og deres oversættelser til Dansk
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
Paediatric plaque psoriasis age 8 years and above.
Erythrodermic psoriasis can frequently lead to unstable plaque psoriasis.
Erythrodermisk Paediatric plaque psoriasis age 8 years and above.
Børn og unge Pædiatrisk plaque psoriasis fra 8 år og ældre.Streptococcal infections: thanks to some evidence it was revealed that streptococcal infections entail plaque psoriasis.
Streptokokinfektioner: takket være nogle beviser det blev afsløret, at streptokokinfektioner medfører plaque psoriasis.Paediatric Plaque Psoriasis Outcomes at 12 Weeks Enbrel 0.8 mg/ kg Once.
Resultater for pædiatrisk plaque psoriasis efter 12 uger.Ilumetri is indicated for the treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy.
Ilumetri er indiceret til behandling af voksne med moderat til svær plaque psoriasis, der er kandidater til systemisk terapi.Patients also had plaque psoriasis with a qualifying target lesion 2 cm in diameter.
Patienterne havde også plaque psoriasis med et læsionsmål på ≥ 2 cm i diameter.Additionally, the pharmacokinetics of Enbrel in rheumatoid arthritis patients,ankylosing spondylitis and plaque psoriasis patients are similar.
Herudover er Enbrels farmakokinetik den samme forpatienter med reumatoid artrit, ankyloserende spondylitis og plaque psoriasis.If you have moderate to severe plaque psoriasis, you will first be given other medicines or e.g. phototherapy.
Hvis De har moderat til svær plaque psoriasis, vil De først få andre lægemidler eller f. eks. behandling med lys.Stelara has been compared with placebo(a dummy treatment)in two main studies involving a total of 1,996 adults with moderate to severe plaque psoriasis.
Stelara er blevet sammenlignetmed placebo(en virkningsløs behandling) i to hovedundersøgelser, der omfattede i alt 1. 996 voksne med moderat til svær plaquepsoriasis.If you have forms of psoriasis other than plaque psoriasis for instance other more severe forms.
Hvis De har andre for Enbrel treatment should be initiated and supervised by specialist physicians experienced in the diagnosis andtreatment of juvenile idiopathic arthritis or paediatric plaque psoriasis.
Behandling med Enbrel bør iværksættes og overvåges af specialister med erfaring i diagnosticering ogbehandling af juvenil idiopatisk artrit eller pædiatrisk plaque psoriasis.In a study of 66 patients with moderate plaque psoriasis, immune responses during and after Raptiva treatment were investigated.
I et studie med 66 patienter med moderat plaque psoriasis blev immunresponset undersøgt under og efter behandling med Raptiva.Erythrodermic psoriasis is a for the most part inflammatory type of disease that is frequently spread on the whole body.Erythrodermic psoriasis can frequently lead to unstable plaque psoriasis.
Erythrodermisk Stelara is used to treat adults with moderate to severe plaque psoriasis a disease causing red, scaly patches on the skin.
Stelara anvendes til behandling af voksne med moderat til svær plaquepsoriasis en sygdom, som fremkalder røde, afskallende pletter på huden.Patients with paediatric plaque psoriasis(aged 4 to 17 years) were administered 0.8 mg/ kg(up to a maximum dose of 50 mg per week) of etanercept once weekly for up to 48 weeks.
Pædiatriske patienter med plaque psoriasis Patienter Raptiva is used for the treatment of adults with moderate to severe chronic(long-term) plaque psoriasis a disease causing red, scaly patches on the skin.
Raptiva anvendes hos voksne med moderat til svær kronisk plaque psoriasis en sygdom, der giver røde, skællende områder på huden.Patients in both studies had plaque psoriasis Body Surface Area[BSA]≥ 10% and Psoriasis Area and Severity Index[PASI] score≥ 12.
Patienter i begge undersøgelser havde plaque psoriasis Body Surface Area[BSA] ≥ 10% og These mean concentrations were similar to those seen in adult patients with plaque psoriasis treated with 25 mg etanercept twice weekly.
Disse middelkoncentrationer var de samme som dem, der blev observeret hos voksne patienter med plaque psoriasis behandlet med 25 mg etanercept to gange om ugen.Treatment of chronic severe plaque psoriasis in children and adolescents from the age of 8 years who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies.
Pædiatrisk SPIRIT evaluated the efficacy of infliximab induction therapy in 249 patients with plaque psoriasis that had previously received PUVA or systemic therapy.
SPIRIT vurderede effekten af infliximab induktionsbehandling hos 249 patienter med plaque psoriasis, som tidligere havde fået PUVA eller systemisk behandling.Enbrel was compared with placebo in 51 children with polyarticular juvenile idiopathic arthritis, 205 adults with psoriatic arthritis, 357 adults with ankylosing spondylitis, and 1,263 adults and211 children with plaque psoriasis.
Enbrel blev sammenlignet med placebo hos 51 børn med polyartikulær juvenil idiopatisk artritis, 205 voksne med psoriasisgigt, 357 voksne med ankyloserende spondylitis(Bekhterevs sygdom) og1 263 voksne og 211 børn med plaque- psoriasis.Enbrel has also been studied in 1,180 patients with plaque psoriasis for up to 6 months in 4 double-blind placebo- controlled studies.
Enbrel er også undersøgt i 4 dobbeltblinde placebo- kontrollerede 6 måneders undersøgelser hos 1. 180 patienter med plaque psoriasis.The Committee for Medicinal Products for Human Use(CHMP) decided that Enbrel' s benefits are greater than its risks for treatment of rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis,ankylosing spondylitis and plaque psoriasis.
Udvalget for Humanmedicinske Lægemidler(CHMP) konkluderede, at fordelene ved Enbrel opvejer risiciene ved behandling af leddegigt, polyartikulær juvenil idiopatisk artritis, psoriasisgigt,ankyloserende spondylitis(Bekhterevs sygdom) og plaque- psoriasis.STELARA is used to treat moderate to severe plaque psoriasis in patients who cannot use or did not respond to other medicines and phototherapy.
STELARA bruges til behandling af moderat til svær plaque- psoriasis hos patienter, der ikke kan bruge eller ikke reagerer på andre medicintyper eller lysbehandling.This section presents data from one study in polyarticular juvenile idiopathic arthritis, four studies in adults with rheumatoid arthritis,one study in paediatric patients with plaque psoriasis, and four studies in adults with plaque psoriasis.
Kliniske forsøg Dette afsnit indeholder data fra én undersøgelse af polyartikulær juvenil idiopatisk artrit, fire undersøgelser af reumatoid artrit hos voksne,en undersøgelse af pædiatriske patienter med plaque psoriasis og fire undersøgelser af plaque psoriasis hos voksne.The safety and efficacy of Raptiva in moderate to severe plaque psoriasis patients has been demonstrated in five randomized, double-blind, placebo-controlled trials at the recommended dose n=1742.
Sikkerheden og effekten af Raptiva hos patienter med moderat til svær plaque psoriasis blev vurderet i fem randomiserede, dobbeltblindede, placebokontrollerede studier med den anbefalede dosis n=1742.Enbrel treatment should be initiated and supervised by specialist physicians experienced in the diagnosis and treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis,ankylosing spondylitis, plaque psoriasis or paediatric plaque psoriasis.
Behandling med Enbrel bør iværksættes og overvåges af specialister med erfaring i diagnosticering og behandling af reumatoid artrit, juvenil idiopatisk artrit, The Committee decided that Stelara' s benefits are greater that its risks for the treatment of moderate to severe plaque psoriasis in adults who failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapies including ciclosporin, methotrexate and PUVA.
Udvalget konkluderede, at fordelene ved Stelara er større end risiciene, hvad angår behandling af moderat til svær plaquepsoriasis hos voksne, der ikke har reageret på, har en kontraindikation mod eller er intolerante over for andre systemiske behandlinger, herunder ciclosporin, methotrexat og PUVA.Clinical efficacy and safety The safety and efficacy of ustekinumabwas assessed in 1,996 patients in two randomised, double-blind,placebo-controlled studies in patients with moderate to severe plaque psoriasis and who were candidates for phototherapy or systemic therapy.
Klinisk effekt og sikkerhed Sikkerheden ved og effekten af ustekinumab er blevet vurderet hos 1. 996 patienter i 2 randomiserede, dobbeltblinde,placebokontrollerede forsøg hos de patienter med moderat til svær plaque- psoriasis, som var egnede til lysbehandling eller systemisk behandling.
